Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Evaluation of intrapatient variability in bioavailability of Technosphere insulin compared with subcutaneous regular insulin in patients with type 2 diabetes.

Trial Profile

Evaluation of intrapatient variability in bioavailability of Technosphere insulin compared with subcutaneous regular insulin in patients with type 2 diabetes.

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Jun 2011

At a glance

  • Drugs Insulin; Insulin
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacokinetics
  • Sponsors MannKind Corporation
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 28 Jun 2011 Actual end date (Mar 2005) added as reported by ClinicalTrials.gov.
    • 14 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top